← All trials
NCT05204329
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2022
- Primary completion
- Jan 1, 2025
- Completion date
- Jan 1, 2025
- First posted
- Jan 24, 2022
- Last posted
- Jan 24, 2022
- Enrollment
- 18
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of Illinois at ChicagoLead sponsor
- National Institutes of Health (NIH)Collaborator
- National Eye Institute (NEI)Collaborator
- University of Illinois at ChicagoOverall official - principal investigator
- University of Illinois at ChicagoReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.